Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.1369
-0.0040 (-2.84%)
Jul 13, 2026, 9:57 AM EDT - Market open
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $2.66 million as of July 13, 2026. Its market cap has decreased by -65.37% in one year.
Market Cap
2.66M
Enterprise Value
-1.63M
1-Year Change
-65.37%
Ranking
Category
Stock Price
$0.14
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $2.66M, a decrease of -99.03%. That is a compound annual growth rate of -62.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 2.66M | -68.88% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onconetix | 3.47M |
| Creative Medical Technology Holdings | 3.37M |
| Virax Biolabs Group | 3.25M |
| Decoy Therapeutics | 3.14M |
| GRI Bio | 3.08M |
| Clearmind Medicine | 3.02M |
| SciSparc | 2.69M |
| Oragenics | 2.64M |